Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme launches first tests for colon cancer risk:

This article was originally published in Clinica

Executive Summary

Genzyme Genetics has launched two tests in the US designed to screen individuals at increased risk from two types of hereditary colon cancer. The first test detects mutations associated with hereditary nonpolyposis colon cancer (HNPCC), the most common form of hereditary colon cancer which affects between 4,000 and 8,000 people (or between 3% and 6% of all colorectal cancers) each year in the US. The second test is for a mutation associated with adenomatous polyposis coli, a type of colorectal cancer which is particularly prevalent in Ashkenazi Jews. The APCI1307K mutation that the test detects is found in almost 30% of Ashkenazi Jews with a personal and family history of this type of cancer. The new tests will only be available through specialised cancer centres for patients with a family history of these types of cancer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT078838

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel